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ABSTRACT
This study was conducted to determine if the p38 and ERK1/2 MAPK pathways are
involved in transcription of IL-6, IL-8, and COX-2 in the chicken thrombocyte response to
ligation of Toll-like receptor 4 (TLR4) by Salmonella minnesota lipopolysaccharide (LPS).
Thrombocytes were isolated and subsequently treated with either p38 MAPK or ERK inhibitor,
and then with LPS during in vitro cell culture. Transcription of IL-6, IL-8, and COX-2 mRNA
was determined using real-time PCR. The experiments were repeated using pM, nM and µM
concentrations of both inhibitors to test cell sensitivity. Stimulation with LPS induced expression
of IL-6, IL-8 and COX-2 mRNA. This expression was reduced by treatment with 25 µM ERK
inhibitor as well as by treatment with 70 µM p38 MAPK inhibitor. However, treatment with 25
pM and nM ERK inhibitor, and with 70 pM and nM p38 MAPK inhibitor, yielded no decrease in
mRNA expression in relation to treatment with LPS alone. Inhibition with both the ERK and p38
MAPK inhibitors was in accordance with previously established concentrations for mammalian
cells. It is now apparent that the p38 and ERK1/2 MAPK pathways are both linked to gene
expression of a cytokine, a chemokine and an enzyme involved in the thrombocyte innate
response to TLR4 ligation by bacterial LPS.
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LITERATURE REVIEW
Avian Innate Immunity
The innate immune system of aves is similar to that of mammals. Many components such as
cytokines, complement, and TLRs have proven to be highly conserved, with the exception of
some blood cells (e.g., heterophils, thrombocytes).
Chickens also have many of the same innate immune cells found in mammals. Dendritic
cells engulf, process, and present pathogens to naïve T cells using finger-like extensions.
Immature dendritic cells circulate in the blood prior to migration into tissues. At this point, they
are capable of migrating to secondary lymphoid tissue to stimulate maturing T cells. Monocytes
and macrophages are also part of chicken innate immunity. At the time of hatch, chicken
macrophages are fully capable of phagocytosis (Qureshi et al, 2000). Monocytes are leukocytes
produced in the bone marrow which enter the bloodstream and, after a few days, migrate into the
tissues. Once in the tissues, they mature into macrophages. Macrophages phagocytize, process,
and present antigens complexed with class II MHC to stimulate sensitized T cells against the
presented antigen.
Interestingly, chickens lack the variety of granulocytes found in the mammalian immune
system, including functional eosinophils (Vegad & Katiyar, 1995; Kaiser et al, 2005). The
primary granulocyte is the heterophil, the avian counterpart to a neutrophil. Like macrophages,
heterophils are highly phagocytic. In addition, they secrete proteolytic enzymes and reactive
oxygen intermediates (Kogut et al, 2001; Swaggerty et al, 2003). However, the contents of
heterophilic granules differ significantly from those of neutrophils (Harmon, 1998). They contain
cationic peptides, lysozyme, acid phosphatase, acid hydrolases, Cathepsin, and α-glucosidase
(Brune and Spitznagel, 1973; Rausch and Moore, 1975; Daimon and Claxton-Martins, 1977;
Fujimori and Yamada, 1978; Maxwell, 1984). Chickens also have cells homologous to
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mammalian natural killer (NK) cells. They bear a phenotypic resemblance to mammalian NK
cells and display cytotoxic activity against target cell lines (Gobel et al, 1994). These cells are
large granular lymphocytes characterized by intracellular expression of CD3 and a lack of
receptors definitive of B or T lymphocytes (Gobel et al, 1994). It was previously believed that
they were capable of cytolytic activity upon leaving the bone marrow, but in 2004 it was
discovered that human NK cells require stimulation, possibly by T-cell secreted IL-2, for
cytolytic activity to occur (Ferlazzo et al, 2004). Unlike human NK cells, chicken NK cells do
not express MHC class II (Gobel et al, 1994). Chickens also have mast cells, which mediate
anaphylaxis as well as the response to parasitic infection. Chicken mast cells are similar to those
in mammals, degranulating upon stimulation, to release histamine and other preformed mediators.
Secreted factors act to recruit granulocytes, lymphocytes, and monocytes or macrophages to the
site of infection (Lin & Befus, 1999). In the avian gut, mast cell histamine release is associated
with ion secretion leading to secretory diarrhea, which aids in bacterial clearance (Collins et al,
2007). Chicken mast cells are most prevalent in the ovaries and the lamina propria of the small
intestine (Swayne and Weisbrode, 1990). Our laboratory also observed them in the Harderian
gland (Scott et al, 2005) lining the subepithelium of the ducts. Rose et al (1980) found that they
have the same preformed immune mediators as their mammalian counterparts.
Chicken thrombocytes are the avian counterpart to mammalian platelets. Like platelets,
they primarily function in hemostasis, but in contrast to platelets, are nucleated. This means that
thrombocytes are capable of responding to external stimuli by altering gene expression. They are
morphologically similar to leukocytes, and also have a role in innate immunity and activation of
acquired immunity (Traill et al, 1983). Activated thrombocytes express a range of immune
mediators including cytokines, chemokines, leukotrienes, and prostaglandins. In addition to
birds, nucleated thrombocytes can be found in reptiles and fish. While they primarily function in
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coagulation, these cells are also phagocytic, having many lysosomes containing acid phosphatase,
basic proteins, and fatty acids (Wigley et al, 1999; Sweeny & Carlson, 1968). They number
between 20 and 30 thousand per milliliter of blood, and comprise over 90% of adherent cells in
the peripheral blood, (Campbell, 1988; Grecci et al, 1980). Unlike heterophils, these cells are
incapable of undergoing oxidative burst (Lam, 1997). Thrombocytes are of interest because,
among other reasons, they are the most abundant leukocytes in circulation.
Mammalian platelets are formed by blebbing off large cells, megakaryocytes, located in
the bone marrow. Circulating platelets are generally viable for 7 to 10 days (Weiss, 1975). Being
non-nucleated, they have no genomic DNA, but do contain mRNA and transcriptional machinery
derived from the megakaryocyte (Healy et al, 2006). Interestingly, pre-mRNA, found only in the
cell nucleus, has been detected in platelet cytoplasm (Denis et al, 2005). Some primary
transcripts found in platelets include TNF-β, IL-7, Stem Cell Factor, cMpl, IgE receptor subunits,
and nuclear factor-E2, a transcription factor (Soslau et al, 1997). When stimulated, they express
new receptors for adhesive proteins, aggregate, and release cytokines (Gear and Camerini, 2003).
Platelets also make direct contact with granulocytes, endothelial cells, monocytes, and
lymphocytes in order to activate them (Halvorsen et al, 1993; Klinger, 1997; Gear and Camerini,
2003). Each cell has approximately 35 α granules containing platelet derived growth factor,
clotting factors, and platelet factor 4 (Klinger, 1997). They also have dense bodies containing
serotonin, epinephrine, histamine, dopamine, ADP, ATP and calcium (Holmsen & Weiss, 1979;
Wurzinger, 1990).
Avian thrombocytes express many of the same receptors and secreted factors as platelets.
These include CD40L, which binds to the CD40 on B cells to aid in stimulation and survival, on
macrophages to stimulate nitric oxide synthesis, and on bursal lymphoma cells to induce
apoptosis (Tregaskes et al, 2005). Also common to both platelets and thrombocytes are
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glycoproteins IIb and IIIa, which mediate cohesion leading to formation of the hemostatic plug
(Kunicki & Newman, 1985). Thrombocytes also express MIP-1β, a chemokine that recruits and
activates granulocytes, and platelet derived growth factor, which stimulates angiogenesis (Lam,
2002; Horiuchi et al, 2001). Other factors include β-thromboglobulin, a marker of thrombocyte
activation, anti-apoptotic factors, lysosomal compounds, and B-G associated class III MHC
antigens (Wachowicz and Krakewski, 1979; DaMatta et al, 1999; Taffarel and Oliveira, 1993;
Daimon and Uchida, 1982; Salomonsen et al, 1991).
As research on thrombocytes has accumulated, it has become obvious that these cells
serve a role in more than just coagulation and phagocytosis. It is now clear that they are integral
in the avian response to pathogenic invasion. Traill et al (1983) demonstrated that anti-bursal cell
serum identifies markers common to B cells and thrombocytes. Higashihara et al (1986) showed
that thrombocytes share a polypeptide with MDCC-MSB1 cells. The K1 antibody, which has
been used to discriminate thrombocytes from B and T cells via flow cytometry, binds a
heterodimeric adhesion molecule expressed on both macrophages and thrombocytes of the
chicken (Kaspers et al, 1993; Bohls et al, 2005). Anti-VLA4 recognizes markers on
thrombocytes, hematopoietic progenitor cells, and eosinophils (McNagny et al, 1992). Along
with the numerous secreted immune modulators, thrombocytes have many surface antigens
characteristic of immune cells.
It has been demonstrated that avian thrombocytes express multiple TLRs, a critical and
highly conserved component of the innate immune system in vertebrates (T. Scott and M. Owens,
unpublished data). Bursal cDNA was first used to demonstrate the presence and functionality of
chicken TLR2 (Fukui et al, 2001). More recently, differential induction of nitric oxide via TLR
ligation was demonstrated in turkey monocytes (He et al, 2008). Scott and Owens (2008)
demonstrated mRNA expression of TLR4 and gene expression via the NFκB and ERK
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intracellular signal pathways. This work demonstrated not only that these cells respond to a
pathogen associated molecular pattern (PAMP) via a highly conserved MAPK pathway, but also
that they express IL-6 and COX-2 in response to bacterial stimulation (Scott and Owens, 2008).
Pathogen recognition often begins with binding of a bacterial or viral component such as
lipopolysaccharide or dsRNA by a TLR. Ligation of TLRs results in activation of specific signal
pathways, many of which are also highly conserved. Initiation of the intracellular signal leads to
alteration of gene expression and results in production of some type of response, such as secretion
of pro-inflammatory molecules.
Chickens express many orthologues of human TLRs. Thus far, orthologues of mammalian
TLR-1 -2, -3, -4, -5, -7, and one similar to TLR-1, 6, and 10 have been identified. These will be
discussed further below.
Avian cells express an array of cytokines that is more narrow in scope compared to
mammalian systems (Hughes et al, 2007). Cytokines are secreted glycopeptides that bind
specific target receptors, initiating an intracellular signal cascade. Depending on the cytokine and
target cell, the signal cascade leads to a response, often a change in gene expression. Cytokines
can be subdivided into interleukins (IL), tumor necrosis factors (TNF), transforming growth
factors (TGF), interferons (IFN), colony stimulating factors (CSF), macrophage inflammatory
protein (MIP) and monocyte chemoattractant protein (MCP). In general, there is low homology
between avian and human cytokine sequences (Kaiser et al, 2005).
In the IL subclass of cytokines, chickens express orthologues to IL-1β, -10, -19, -22, -26, four
subtypes of IL-17, most TH1, TH2, and T cell-proliferative interleukins, and IL-3, 6, 7, 9, and 16
(Kaiser et al, 2005). Most ILs are expressed by leukocytes, although many non-immune cells
secrete them as well. They serve a variety of functions, including recruitment of immune cells to
sites of infection, and inducing proliferation and activation of cytolytic cells.
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IFNs are secreted by immature dendritic cells and virally infected cells in response to
infection or tumor growth. They inhibit viral RNA production (Type I) and activate (Type II)
natural killer cells and macrophages. In chickens, orthologues to human IFN-α, -β, and –γ have
been discovered thus far (Guo et al, 2008). Ligation of many IFN receptors results in activation
of the JAK/STAT signal pathway and p53-mediated apoptosis in target cells. IFNs also initiate or
upregulate expression of certain genes, such as that for the Myxovirus resistance protein (Mx).
This protein has intrinsic GTPase activity and is used for sensing the presence of “nucleocapsidlike structures” during infection. It also traps viral components in areas of the cell where new
viral particles cannot be assembled (Li et al, 2007). Ligation of IFN receptors also leads to
production of Very Large Inducible GTPase 1 (VLIG-1) (Guo et al, 2008). This is a large
enzyme that regulates transcription of hundreds of genes involved in pathogen defense (Klamp et
al, 2003).
TNFs bind target receptors to initiate a signal cascade leading to cell death via the caspase
pathway. Chickens express ten known TNF-like cytokines (Kaiser et al, 2005). They bind target
receptors on endothelial cells to increase vascular permeability, thus allowing an influx of
immune cells and other inflammatory molecules. Most TNF receptors are type II transmembrane
proteins, meaning they make a single pass through the lipid bilayer, and the N-termini lie on the
cytoplasmic face of the plasma membrane.
Chemokines, a subclass of cytokines, are 67-127 amino acid-long glycoproteins that function
to draw immune cells into an area of damage or site of infection. Most are secreted, but a few
exist which are membrane-bound (Kaiser et al, 2005). The chicken repertoire of chemokines
differs significantly from that of mammals (Guo et al, 2008). Chemokines are categorized into
subfamilies based on the first two N-terminal cysteine residues. In CXCL chemokines, these
residues are separated by one amino acid. The cysteine residues are adjacent in the CCL
6

subfamily. XCL chemokines have only two cysteine residues, with one near the N terminus and
the other downstream. The few known CX3CL chemokines have three amino acids separating the
two N-terminal cysteines.
Chemokines are a critical component of the innate arm of the immune system. They can have
endocrine, paracrine, or autocrine function, and mediate inflammation as well as hematopoiesis.
Thus far, orthologue genes to human CCL-1 through -5, -8, 11, -13, -15, -16, -18, and -23 have
been discovered. In addition, orthologues to CXCL-1 through -8, CXCL-12 through -14,
CX3CL1, and XCL-1 have been discovered (Kaiser et al, 2005). CCL chemokines are grouped
into the MIP and MCP families (Kaiser et al, 2005). Functionally, chemokines are divided into
those which enhance cytokine (type I) responses and those that enhance antibody (type II)
responses. Some chicken cytokines with known functions include CXCR4, which is involved in
regulation of progenitor cell trafficking, XCL-1, which is a T cell chemoattractant, CXCL13, a B
cell attractant, and CAF, a chemotactic and angiogenic factor (Tamamura et al, 2006; Moser et al,
2004; Kaiser et al, 2005). Ah294 is a possible orthologue of mammalian CCL5, which is a
chemoattractant for monocytes, memory TH cells, and eosinophils (Hughes et al, 2007).
Phylogenetic analysis groups the chicken ah221 gene with the mammalian MCP family of
cytokines (Hughes et al, 2001).

Toll-like Receptors
TLRs are highly conserved members of the IL-1 receptor family that can be found on cell
surface and internal compartment membranes across many animal phyla (Boyd et al, 2007). They
were named for their structural similarity to a protein coded by the Drosophila Toll gene which is
required for the establishment of the dorsal-ventral axis in developing larvae (Medzhitov et al,
1997). Later, these receptors were identified as a critical component of the innate immune
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system. Members of IL-1R family share an approximately 200 amino acid cytoplasmic region
called a TIR (Toll/IL1R) domain. Extracellular regions contain leucine-rich repeat domains
(Akira, 2003). All TLRs have leucine-rich repeats and one or two cysteine-rich regions in the
ligand-binding region of the external domain (Kindt et al, 2007). A short transmembrane domain
spans the plasma membrane. The cytoplasmic, or TIR (Toll/IL-1R) domain of these receptors is
structurally similar to the cytoplasmic domain of the IL-1 receptor, and is very much homologous
among the different TLRs.
At present, eleven TLRs have been identified in humans and mice. Eight human orthologues
have been identified in chickens (Iqbal et al, 2005). Most TLRs function as either hetero- or
homodimers, and all bind to a specific bacterial or viral component. Collectively, these
components are called pathogen associated molecular patterns (PAMPs), and are conserved
among the types of pathogens in which they are found.
Mammalian TLRs that reside on internal membranes include TLR-3, -7, -8, and -9. These
internal receptors bind PAMPs found inside infected cells, including double- and single-stranded
viral RNA, and CpG dinucleotides of bacterial DNA. TLR-1 and -2 dimerize on the plasma
membrane to bind components of bacterial parasites (Kindt et al, 2007). TLR-2 and -6 dimerize
to bind components of gram positive bacteria and fungi (Kindt et al, 2007). TLR-4 monomers
come together to bind lipopolysaccharide (LPS), a major component of gram negative bacterial
cell walls. This homodimer also binds the F protein of respiratory syncytial virus. Finally, TLR5 forms a homodimer to bind flagellin (Kindt et al, 2007). The functions of human TLR-10 and 11 are at present unknown.
In the avian immune system, human orthologues of TLR-1 through TLR -7 have been
identified (Iqbal et al, 2005). To date, no avian orthologues of TLR-8, -9, or -10 have been
discovered (Yilmaz et al, 2005). TLR-2 and -4 are the best characterized thus far. Two isoforms
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of chicken TLR-2 have been reported, and interrupted remnants of the gene for one of these
isoforms was discovered in the human genome, suggesting that gene duplication occurred prior to
the divergence of mammals and birds 300 million years ago (Boyd et al, 2007). While the two
isoforms of chicken TLR2 share 88.5% nucleic acid identity, only isoform 2 has demonstrated a
strong response to classic mammalian TLR2 agonists (Fukui et al, 2001). Both TLR-2 and -4
share around 50% amino acid sequence identity with the human counterparts, and evidence
suggests that these TLRs were distinct before the divergence of mammals and birds (Yilmaz et al,
2005).
As in mammals, TLR4 ligation is responsible for eliciting the avian immune response to LPS.
It was previously believed that TLR2 isoform 2 bound LPS to initiate this response, but a 2008
study revealed that this response is generated exclusively by TLR4 in conjunction with MD
(myeloid differentiation protein)-2 (Keestra & van Putten, 2008). In the mammalian system, LBP
binds LPS and transfers it to CD-14, which then delivers the molecule to MD-2 (PallsonMcDermott & O’Neill, 2004). The conformational change induced in MD-2 by LPS ligation
triggers transfer of the molecule to TLR4 (Kim et al, 2007; Ohto et al, 2007). In this study, a
protein similar to CD14 was discovered, but no orthologue to LBP was apparent (Keestra & van
Putten, 2008). It seems, however, that CD14, MD-2, and LPS interaction during initiation of the
LPS response is similar in chickens and mammals (Keestra & van Putten, 2008). While all other
known TLRs aside from TLR3 activate only MyD88-dependent signal pathways, TLR4 ligation
recruits multiple adapter molecules, namely TIRAP (in the MyD88 dependent pathway), TRAM
(TRIF-related adapter molecule), and TRIF (TIR-domain-containing adapter-inducing IFN-β)
(Keestra & van Putten, 2008). Dual activation of TRIF and TRAM is unique to the TLR4activated pathway (Yamamoto et al, 2003). The authors of this publication attribute the previous
judgment on TLR2-LPS ligation to contaminating lipoproteins (Hirschfeld et al, 2000). In some
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genetic lines of chickens, TLR4 has been mapped to a gene region associated with susceptibility
to Salmonella infection (Leveque et al, 2003).
TLRs are highly conserved receptors, the ligation of which activates highly conserved
intracellular signal cascades. Activation of these cascades leads to a variety of responses,
depending on the ligand and cell type. TLRs are a critical component of the innate immune
system in all animal phyla examined to date. TLR4, in particular, allows immune cells such as
avian thrombocytes and mammalian macrophages to initiate a local response to invading gram
negative bacteria through activation of both MyD88-dependent and -independent MAPK
pathways.
Intracellular Signal Cascades in the Innate Immune Response
Ligation of all TLRs induces activation of intracellular signaling cascades. In particular, the
p38 mitogen-activated protein kinase (MAPK), extracellular-signaling regulated kinase (ERK),
and Nuclear factor (NF)-κB pathways are activated. Induction of these pathways via TLR
ligation activates cell-mediated immunity, apoptosis, antimicrobial peptide production, or proinflammatory molecule production. TLR ligation recruits MyD88 to the TIR domain of the
receptor. The IRAK1/IRAK4 complex then docks on MyD88, and IRAK4 phosphorylates
IRAK1, creating a binding site for TRAF6. The newly formed IRAK1/TRAF6 complex
dissociates from IRAK4 to activate TAK1. From this point, TAK1 may activate IKK in the
NFkB or MEK in the p38 MAPK pathway. TAK1 also leads to activation of TPL2, which then
activates MKK1/2 in the ERK1/2 pathway (Banerjee & Gerondakis, 2007).
ERK1/2 can be found in varying levels in all tissues (Chen et al, 2001). Activation of the
ERK pathway via TLR4 ligation begins with recruitment of Ras to the cytoplasmic tail of TLR4.
Ras binds temporarily to a docking site on the tail and recruits Raf1. Raf1 phosphorylates and
activates MEK1/2, a serine/threonine kinase, which in turn phosphorylates and activates ERK1/2.
10

ERK1/2 is then free to enter the nucleus and activate Elk, a transcription factor. Ligation of
peptidoglycan by TLR2 and CpG by TLR9 also induce activation of the ERK pathway via Ras.
However it is important to note that ERK activation via TLR4 ligation is Ras-independent (Chen
et al., 2004; Xu et al., 2003; David et al., 2005). The ERK pathway has traditionally been linked
to cell survival and proliferation, but recent research shows that it is also integral to the innate
immune response (Roux & Blenis, 2004; Galdiero et al, 2005).
Inhibition of MEK1/2 in the ERK pathway in U937 human monocytic leukemia cells as well
as in chicken thrombocytes has led to decreased mRNA expression of TNF-α, IL-1β, and COX-2
(Galdiero et al, 2005; Scott & Owens, 2008). Interestingly, LPS-induced expression of IL-6 and 8 are unchanged in U937 cells after treatment with PD98059 (Galdiero et al, 2005). However,
LPS-induced expression of IL-6 and TNF were suppressed in alveolar macrophages treated with
MEK1 inhibitor PD98059 (Carter et al, 1999).
TLR-4 ligation also leads to activation of the p38 MAPK cascade. This pathway, unlike the
ERK pathway, has traditionally been linked to inflammation (Chae et al, 2005). Ligation leads to
activation of TAK, which phosphorylates and activates MEK3/6. MEK3/6 then phosphorylates
and activates p38. This molecule then enters the nucleus and activates MSK1/2 which leads to
transcription of pro-inflammatory molecules, including IL-6, IL-1, TNF-α and IL-8 (Galdiero et
al, 2005; Scott and Owens, 2008).
Inhibition of p38 suppresses LPS-induced production of TNF-α, IL-6, and IL-10 in humans
(Kaminska, 2005). As with the ERK pathway, inhibition of the p38 MAPK pathway using
SB203580 significantly lowered the levels of IL-6 and TNF produced in human alveolar
macrophages stimulated with LPS (Carter et al, 1999). In contrast, Galdiero et al (2005) found
that LPS-induced expression of IL-6 and -8 was unchanged when U937 human monocytic cells
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were treated with SB203580. In murine macrophages, this pathway is apparently critical for
expression of IL-6 and -12 (Zhu et al, 2005).
Despite varying results for expression of specific cytokines, it is clear that the p38 MAPK
and ERK pathways are critically involved in inflammation. Furthermore, these pathways appear
to be highly conserved, as their involvement in regulation of the inflammatory response has been
demonstrated in mice, humans, and chickens, among others (Zhu et al, 2005; Galdiero et al, 2005;
Scott and Owens, 2008; Aggeli et al, 2001).
The present study is an expansion upon previous research in our laboratory, which
demonstrated the involvement of the ERK and NFκB pathways in the thrombocyte inflammatory
response to LPS stimulation. This work has been expanded to include the p38 MAPK pathway,
which, in many other organisms, is integral in the inflammatory response. In addition, this study
has focused on the involvement of MAPKs rather than MAPKKs in the expression of
inflammatory molecules. Expression of a cytokine, a chemokine, and an enzyme in response to
LPS stimulation was examined. It was found that both the ERK and p38 MAPK pathways are
involved in the thrombocyte response to LPS, and that both pathways regulate expression of
interleukin-6, interleukin-8 and cyclooxygenase-2.
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INTRODUCTION
Avian thrombocytes serve a similar hemostatic function as mammalian platelets and are
the most numerous of all chicken leukocytes, playing an integral role in innate immunity
(Horiuchi, et. al, 2004). Thrombocytes bind bacterial lipopolysaccharide (LPS) through TLR4,
which initiates an inflammatory response (Ferdous et al., 2008; Scott and Owens, 2008). Part of
the general innate response is the production of pro-inflammatory molecules including IL-6, IL-8
and cyclooxygenase-2 (COX-2). IL-6, a cytokine, initiates an inflammatory response to
pathogens, activates both T and B lymphocytes, and promotes the differentiation of monocytes
into macrophages (Gessani et al., 1993; Burdin et al., 1995; Rincon et al., 1997). IL-8, a CXC
chemokine, is released locally at sites of infection or tissue damage. Upon release, this
chemokine acts as a chemoattractant, recruiting heterophils which are activated to further enhance
inflammatory responses to pathogens. COX-2 is an enzyme that catalyzes the initial conversion
of arachadonic acid to various prostanoids, primarily PGE2, PGD2, and thromboxane A2.
Prostanoids are then released by cells to act as inflammatory mediators affecting surrounding
tissues (Herlong and Scott, 2006).
Unlike thrombocytes, mammalian platelets lack nuclei and thus also the capacity to
respond to pathogenic invasion through gene expression. Platelets do, however, store CC and
CXC chemokines, cationic peptides, interleukins, and adhesive compartmentalized α-granules
(Klinger and Jelkmann, 2002). Upon stimulation by contact with foreign pathogens, platelets
may degranulate, releasing antimicrobial peptides and inflammatory mediators (Boehlen and
Clemetson, 2001). It has also been shown that platelets are capable of aggregating, engulfing
bacteria and viruses into vacuoles, and then fusing vacuoles with α-granule containing
compartments (Klinger, 1997; Elzey et al, 2005).

13

Ferdous et al. (2008) found that incubating chick thrombocytes with LPS led to a
significant increase in the expression of pro-inflammatory cytokines, specifically IL-1β, IL-6 and
IL-12. Scott and Owens (2008) reported that LPS exposure activated the NF-κB and MEK signal
pathways through TLR4 ligation, and this led to significantly increased gene expression of IL-6
and COX-2, with increased production of PGE2. These two studies by our laboratory were the
first published reports to show increased pro-inflammatory gene expression in thrombocytes
resulting from exposure to LPS. Once gene expression was demonstrated through LPS
activation, Scott and Owens (2008) showed that inhibition of MEK1 by PD98059 blocked this
LPS-induced gene expression, implicating the involvement of this pathway in the expression of
pro-inflammatory responses. That study also demonstrated that inhibition of IKK with inhibitor
BMS345541 significantly reduced the LPS-induced gene expression, documenting the
involvement of the NF-κB pathway in the thrombocyte pro-inflammatory response.
The current study focused on the effects of inhibiting specific signaling molecules in two
MAPK pathways that are implicated in the expression of three pro-inflammatory gene products- a
cytokine, a chemokine and an enzyme- in response to TLR4 binding LPS. SB203580 was used to
inhibit p38, which is directly downstream of MEK3/6 in one of the MAPK pathways. An
inhibitor was used to suppress the activity of ERK, which is directly downstream of MEK1/2 in
another MAPK pathway. These signal molecules were chosen for inhibition because previous
studies in our laboratory have demonstrated the involvement of MEK in pro-inflammatory gene
expression via ERK activation, but it was undetermined what role the p38 MAPK pathway would
have in chicken thrombocyte gene expression for inflammatory responses. Previously, Scott and
Owens (2008) were able to inhibit COX-2 gene expression if MEK1/2 was blocked by PD98059.
IL-6 was unaffected by this inhibitor at the concentration used. Also, there was no prior
information regarding direct ERK or p38 MAPK inhibition on innate responses initiated by TLR4
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binding with LPS. It was supposed, but unknown, that blocking of ERK instead of MEK1/2
would lead to the same altered gene expression previously observed (Scott and Owens, 2008).
This particular pathway, unlike the p38 MAPK pathway, has usually been associated with cell
growth and differentiation rather than initiation of pro-inflammatory responses (Chae et al.,
2005). The p38 MAPK pathway, on the other hand, has been linked to induction of proinflammatory gene expression (Widmann et al., 1999). Since thrombocytes are terminal-stage
cells incapable of further proliferation, would the role of the MEK1/2 to ERK transduction be
different for a cell type completely committed to innate immunity? When MEK1/2 was inhibited
in Scott and Owens’ study (2008), there was a departure of effect between IL-6 and COX-2 gene
expression. Would inhibition at the ERK level reveal a similar departure or would gene
expression for IL-6, IL-8 and COX-2 all be decreased when inhibition occurs at a level closer to
the nucleus? Also, would the assumed p38 MAPK’s role in expression of pro-inflammatory
genes found in other innate cells (i.e. neutrophils, heterophils, and macrophages) be a working
mechanism in chicken thrombocytes? With these questions in mind, a series of experiments were
conducted with the idea that more information could be gathered on TLR4 linked pathways and
gene expression. The data presented were derived from both microarray analysis and real-time
PCR in order to learn more about the pro-inflammatory potential of chicken thrombocytes.
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MATERIALS AND METHODS

Thrombocyte Recovery
Blood was obtained from 9 - 12 week old Single Comb White Leghorn (SCWL) female
chickens. Thrombocytes were isolated by gradient centrifugation according to Scott and Owens
(2008). Viable cell counts were performed using the Trypan blue method and dilutions made so
that each microcentrifuge culture tube contained 1 x 107 cells in a final volume of 1 milliliter.
ERK and p38 MAPK Inhibitors and Thrombocyte Culture
Five milligrams ERK inhibitor (Calbiochem) was resuspended in 1.0 mL dimethyl
sulfoxide (DMSO), producing a 15 mM solution. Inhibitor suspension was added to each ERK
inhibitor-treated tube, resulting in a final inhibitor concentration of 25 µM. An equal volume of
DMSO was added to tubes not treated with inhibitor. One milligram SB203580, p38MAPK
inhibitor (Calbiochem), was resuspended in 1.0 mL DMSO, producing a 2.6 mM solution.
Inhibitor suspension was added to SB203580-treated tubes and an equal volume of DMSO was
added to tubes not treated with inhibitor. This resulted in a final inhibitor concentration of 70
µM.
All tubes were then incubated at 41°C on a rocking platform for 30 min in a humidified
water-jacketed incubator. After 30 min, the tubes were removed and 2 µL (10 µg/mL final
concentration) of lipopolysaccharide from Salmonella minnesota was added to LPS treated tubes.
Two microliters of DEPC treated water was added to those not treated with LPS. All tubes were
incubated at 41°C on a rocking platform for 60 min in a humidified water-jacketed incubator.
The tubes were removed and centrifuged at 5000 x g for 120 s at room temperature. The
resulting supernatant was removed and each cell pellet was resuspended in 100 µL RNAlater™
(Qiagen). All tubes were held frozen at -20°C.
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Preliminary Expriments
Based upon effective inhibitory concentrations from mammalian cell treatment, final
concentrations of 25 µM ERK inhibitor and of 70 µM p38 inhibitor were chosen. To determine if
these concentrations were appropriate for chicken thrombocytes, a preliminary experiment was
performed. Different treatments were applied to four tubes of cells for each inhibitor. The first
tube of cells served as a negative control and was not treated with LPS or inhibitor. The second
tube was treated with inhibitor alone, the third with LPS, and the fourth with both inhibitor and
LPS. Results are found in Appendix 1.
RNA samples from control cells, LPS-stimulated cells, and cells treated with µM
concentrations of each inhibitor with and without LPS stimulation were subjected to microarray
analysis (C. Keeler, University of Delaware). Approximately 4,000 genes potentially involved in
TLR4-linked signal pathways were examined. This was done to verify our initial real-time PCR
results and to further determine the scope of genes induced via TLR4 pathways. These results are
presented in Appendix 2.
First Experiment
In order to determine if there was a difference in response to the inhibitors between two
different genetic lines of chickens, the preliminary experiment described above was repeated with
the same concentrations of inhibitors. However, both inhibitors were used in respective cultures
in order to compare against the same DMSO control. Blood was taken from six birds of each
genetic line for each test.
Second Experiment
Dilutions of both the ERK and p38 inhibitors were made in the pM, nM and µM range to
determine thrombocyte sensitivity to treatment. The treatments in the first experiment were
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repeated, with the addition of 25 pM and nM ERK inhibitor with and without LPS, and 70 pM
and nM p38 inhibitor with and without LPS.
RNA Isolation and Real-Time Reverse Transcriptase Polymerase Chain Reaction
RNA from each tube of cells was extracted according to a previously established protocol
(Scott and Owens, 2008), using a Qiagen RNeasy® kit with the addition of DNase digest. The
final RNA concentration in each treatment tube was determined using a spectrophotometer
(Eppendorf BioPhotometer).
Real-time RT-PCR was performed using the Quantitech SYBR Green RT-PCR kit
(Qiagen). Reactions were completed using 0.5 µM forward and reverse primers for GAPDH, IL6, IL-8 and COX-2 (Table 1). Dilutions were made for all treatments so that each individual
reaction contained 10 ng RNA in a volume of 8 µL. Twelve microliters of master mix containing
buffer, reverse transcriptase, water, and forward and reverse primers were added to each
experimental reaction. Two reactions per treatment per bird were performed. In addition,
Treatment 1 (no inhibitor and no LPS) for each bird was repeated without reverse transcriptase as
a negative control. A “No Template” negative control with DEPC-treated water in place of RNA
was used to ensure purity of master mix components. The cycling profile was 50°C for 30 min.
(reverse transcriptase), 95°C for 15 min. (DNA polymerase), 40 cycles of 94°C for 15 s
(denaturation), 57°C for 20 s (annealing), and 72°C for 20 s (extension).
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mRNA

Primer sequence (5’-3’)

Accession No.

Reference
GAPDH

F

ATGCCATCACAGCCACACAGAAGA

NM_204305

R GCACACGGAAAGCCATTCCAGTAA
Targets
IL-6

F

ATGTGCAAGAAGTTCACCGTGTGC

AJ309540

R TTCCAGGTAGGTCTGAAAGGCGAA
IL-8

F

TTTCAGCTGCTCTGTCGCAAGGTA

AJ009800

R CTTGGCGTCAGCTTCACATCTTGA
COX-2

F

TCCACCAACAGTGAAGGACACTCA

M64990

R ATCCCACTCTGGATGCTCCTGTTT
Table 1. Forward (F) and reverse (R) primer sets for chicken thrombocyte real-time reverse
transcriptase polymerase chain reactions of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), Interleukin-6 (IL-6), Interleukin-8 (IL-8) and cyclooxygenase-2 (COX-2).
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Statistical Analysis
In order to determine treatment differences, least-squares analysis of variance was used to
compare fold-change in mRNA expression of COX-2, IL-6 and IL-8. When appropriate, postANOVA comparisons of treatment means were accomplished by pairwise t-tests. In cases where
the inhibitor controls (inhibitor and no LPS) were not different from the overall untreated control
(no inhibitor and no LPS), the data was presented in bar graphs with the overall untreated control
only representative of all controls.
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RESULTS

Both p38 MAPK and ERK Inhibitors Interfered With mRNA Expression in LPS- Stimulated
Thrombocytes.
In the experiment comparing expression of IL-6, IL-8 and COX-2 in two different genetic
lines of chickens, no differences in expression of these molecules in response to LPS were found,
so the data were pooled for genetic lines. Between the control cells (-/-/-) and those treated with
LPS alone (+/-/-), expressions of IL-6, IL-8 and COX-2 mRNA were significantly different (Fig.
1A, B and C). There were also significant reductions in IL-6, IL-8 and COX-2 mRNA
expressions for LPS stimulated cells treated with p38 MAPK (+/+/-) and ERK inhibitors (+/-/+)
compared to those treated with LPS (+/-/-).
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Figure 1. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2)
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without
p38 MAPK inhibitor SB203580 (70 µM) or ERK inhibitor (25 µM), and then 1h incubation of
thrombocytes (1 x 107) at 41°C in the presence or absence of S. minnesota lipopolysaccharide
(LPS: 10 µg/mL). The mRNA expression of all three molecules varied relative to LPS and
inhibitor treatment combinations. Data are presented as means ± SEM (n=12). **P ≤ 0.01.
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Varying Concentrations of Both p38 MAPK and ERK Inhibitors Interfered with mRNA
Expression in LPS-Stimulated Thrombocytes.
The effect of treating thrombocytes with varying concentrations of the two inhibitors
resulted in varying expression patterns for the three genes of interest. For p38 MAPK inhibitor,
IL-6 and IL-8 expression following LPS stimulation (+/-) was significantly elevated over that of
unstimulated cells (-/-) (Fig. 2A and B), while the COX-2 response was elevated but not
significantly (Fig. 2C). Interestingly, all three pro-inflammatory indicators had high induction of
mRNA following LPS stimulation and inhibitor pre-treatment at the pM concentration. Gene
expressions for all three were reduced at the nM concentration of p38 MAPK inhibitor, and the
µM pre-treatment was effective in blunting LPS stimulated gene expression for all three.
In the experiment using dilutions of ERK inhibitor, treatment with LPS alone (+/-)
significantly induced the expression of IL-6, IL-8 and COX-2 over the control thrombocytes (-/-).
The µM concentration of ERK inhibitor resulted in reduced expression of all three genes while
inhibitor treatment at pM and nM concentrations did not effectively interrupt gene expression in
LPS stimulated thrombocytes (Fig. 3A, B, and C).
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Figure 2. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2)
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without
p38 MAPK inhibitor SB203580 (70 µM, nM or pM), and then 1h incubation of thrombocytes (1 x
107) at 41°C in the presence or absence of S. minnesota lipopolysaccharide (LPS: 10 µg/mL).
The mRNA expression of all three molecules varied relative to LPS and p38 MAPK inhibitor
treatment combinations. Data are presented as means ± SEM (n=6). *P ≤ 0.05, **P ≤ 0.01.
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Figure 3. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2)
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without
ERK (25 µM, nM or pM), and then 1 h incubation of thrombocytes (1 x 107) at 41°C in the
presence or absence of S. minnesota lipopolysaccharide (LPS: 10 µg/mL). The mRNA
expression of all three molecules varied relative to LPS and p38 MAPK inhibitor treatment
combinations. Data are presented as means ± SEM (n=6). *P ≤ 0.05, **P ≤ 0.01.
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DISCUSSION
In chicken thrombocytes, stimulation with LPS leads to a number of inflammatory responses
through TLR4-linked cytoplasmic pathways. The current experiments demonstrated that
expression of IL-6, IL-8, and COX-2 genes are mediated by two of the three major MAPK
signaling pathways. Specifically, both ERK and p38 MAPK pathways regulate gene expression
for these pro-inflammatory molecules.
Previous work in our laboratory (Scott and Owens, 2008) has shown that LPS stimulates the
NF-κB pathway of thrombocytes, resulting in increased expression of IL-6 and COX-2 mRNA
and PGE2 production. It was also demonstrated that MEK1/2 inhibition negatively affected
expression of COX-2, but not IL-6 mRNA. In contrast, downstream ERK inhibition in the
current experiments negatively affected expression of both IL-6 and COX-2, in addition to IL-8.
Furthermore, the p38 MAPK pathway, previously shown to be involved in pro-inflammatory
molecule expression in other innate cells (Khatri and Sharma, 2006; Chen et al., 1999) was also
involved in the chicken thrombocyte innate response.
As reported by Scott and Owens (2008), IL-6 expression increased dramatically in response
to LPS. In the present experiment, too, there was a significant response, and this expression was
suppressed by treatment with µM concentrations of both p38 and ERK inhibitors. Furthermore,
70 nM of p38 inhibitor suppressed the IL-6 response. In a study using LPS-stimulated chicken
heterophils, treatment with PD98059 reduced ERK concentrations (Kogut et al., 2007). In
contrast to Kogut et al. (2007), treatment of thrombocytes with 10 µM PD98059 in our laboratory
did not result in significantly lowered IL-6 expression (Scott and Owens, 2008) as expected. It is
possible that the 10 µM concentration of PD98059 did not affect ERK activity enough to suppress
the IL-6 response or that these are probable differences in pathway sensitivity of heterophils
compared to thrombocytes for this particular inhibitor.
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Treatments with pM and nM concentrations of ERK and p38 inhibitors were ineffective at
suppressing the IL-6 response to LPS. The IC50 of p38 MAPK inhibitor for human monocytes is
50-100 nM (Gallagher et al., 1995), a concentration range that was marginally effective with
chicken thrombocytes. Seventy µM p38 inhibitor was effective at suppressing LPS-induced
expression of IL-6. The listed IC50 for ERK inhibitor is ≤ 25 µM for HeLa, A549, and SUM-159
tumor cells (Kumar et al., 1999; Hancock et al., 2005). This concentration was effective at
suppressing the IL-6 response of chicken thrombocytes.
In heterophils, stimulation with LPS results in increased mRNA expression of IL-6 along
with IL-8 and IL-1β (Kogut et al., 2005). Heterophil receptor-mediated phagocytosis also leads
to increased expression of IL-6 and IL-8 (Kogut et al., 2003). Multiple studies have demonstrated
IL-6 production by heterophils of different genetic lines, both constitutively (Swaggerty et al,
2004) and in response to stimulation with LPS (Kogut et al, 2006). In mammals, this proinflammatory cytokine stimulates neutrophil degranulation and B-cell differentiation, and induces
acute phase proteins (Akira et al, 1990; Kaiser et al, 2000; Swaggerty et al, 2006). IL-6 also
stimulates thrombopoiesis. Administration of IL-6 to C57BL/10 mice resulted in increased levels
of thrombopoietin (TPO) mRNA in the liver, along with increased TPO plasma levels (Kaser et
al, 2001). The increase in TPO mRNA was also accompanied by a significant increase in the
number of circulating platelets (Kaser et al, 2001). When TPO was neutralized in vivo via
injection of anti-TPO polyclonal antibody, this platelet elevation was not seen, indicating that IL6 regulates platelet levels via TPO induction (Kaser et al, 2001).
Though in this experiment expression of IL-8 mRNA increased significantly in response to
treatment with LPS, treatment with pM and nM concentrations of both p38 and ERK inhibitors
were ineffective at suppressing the LPS-induced IL-8 response. However, treatment with 70 µM
p38 inhibitor and with 25 µM ERK inhibitor were both effective at significantly lowering IL-8
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mRNA expression. While thrombocytes are unique, terminal-stage cells, they apparently share
many of the immunological signal pathways existing in other leukocytes. In general, CXC
chemokines such as IL-8 act as chemoattractants for polymorphonuclear cells, while CC and C
chemokines function in macrophage and lymphocyte attraction (Baggiolini et al., 1994; Luster,
1998; Zlotnik and Yoshie, 2000; Zhang et al., 2003). In neonatal chicks, infection with
Salmonella enteritidis results in increased expression of CXCLi2, a chemokine synonymous to
IL-8 that recruits heterophils (Kogut, 2002).
LPS also stimulated thrombocyte expression of COX-2 mRNA, and this response was
suppressed by µM concentrations of both inhibitors. Scott and Owens (2008) previously
demonstrated an increase in COX-2 mRNA expression by thrombocytes in response to LPS. In
macrophages, exposure to Infectious Bursal Disease Virus (IBDV) results in greater expression of
COX-2 and IL-8 mRNA (Khatri and Sharma, 2006) and inhibition of p38 and NF-κB in these
cells suppressed the COX-2 mRNA response. IBDV infection has also been shown to stimulate
production of IL-1β, IL-6, cMGF, and iNOS in chicken macrophages (Kim et al., 1998; Khatri et
al., 2005). In J774 macrophages, inhibition of p38 attenuates LPS-induced COX-2 activity, and
consequently inhibits the release of PGE2 (Chen et al., 1999).
While microarray analysis is a valuable hypothesis-generating tool, the amount and reliability
of pertinent information gained in this study was limited. Microarray data indicated that the p38
MAPK but not the ERK pathway regulates interleukin-8 expression. This is in contrast to RTPCR results, which suggested that both pathways were involved in expression of this molecule
upon TLR4 ligation. The data for IL-6 expression was in accordance with RT-PCR data,
indicating that both pathways regulate expression of this molecule. No information on
cyclooxygenase-2 expression was generated from this experiment. This analysis did, however,
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support the theory that the NFκB pathway in chicken thrombocytes, as in most other systems
examined, predominates MAPK pathways in the inflammatory response to bacterial stimulation.
The current experiments examined the effect of inhibiting two different MAPK pathways on
production of a cytokine, a chemokine, and an enzyme involved in the innate response to
bacterial LPS. Both the ERK and p38 pathways begin with ligation of TLR4 by LPS. The avian
ERK pathway is not yet fully understood, but is known to be Ras-dependent (Kogut et al., 2007).
Ligation of TLR4 activates an undetermined signal molecule, which in turn promotes conversion
of Ras-GDP to Ras-GTP. Ras-GTP activates Raf1, which in turn activates MEK1/2. MEK1/2
phosphorylates and activates ERK1/2, which then phosphorylates and activates Elk-1. Elk-1 then
enters the nucleus and acts as a transcription factor for pro-inflammatory molecules, like those
examined in this study. In the p38 MAPK pathway, ligation of TLR4 results in activation of
TAK, which phosphorylates MEK3/6. MEK3/6 in turn activates p38 (MAP Kinase 14). p38
activates a form of Elk which enters the nucleus and activates transcription of IL-6, IL-8 and
COX-2.
Treatment with 20 to 40 µM PD98059 inhibited phosphorylation of ERK1/2 in limbal
epithelial cultures and suppressed production of IL-8, IL-1β, and TNF-α in response to exposure
to hyperosmolar medium (Li et al., 2006). In immortalized T/C28a2 human chondrocytes,
activation of the ERK, p38 and JNK pathways resulted in enhanced expression of COX-2 and
production of PGE2 (Nieminen et al., 2005). The COX-2 and PGE2 responses were suppressed
by treatment with PD98059. Also, treatment with SB203580 inhibited COX-2 expression and
subsequent PGE2 production at µM concentrations (Nieminen et al., 2005).
Several models show the MAPK pathway involving p38 as the dominant pathway in proinflammatory responses, with the ERK pathway involvement primarily devoted to cell growth
and differentiation events (Widmann et al., 1999; Lai et al., 2001). The results of the current
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study would contradict those models, as stimulation of thrombocytes with LPS resulted in
increased expression of IL-6, IL-8 and COX-2 mRNA which were all inhibited by treatment with
the ERK inhibitor (Fig. 6). The involvement of the ERK MAPK pathway in pro-inflammatory
responses is likely due to the fact that thrombocytes are terminal-stage cells that do not grow or
differentiate. They are short-lived and actively function only in immune responses. The model
for signaling in the thrombocyte (Fig. 6) is now expanded from that proposed by Scott and Owens
(2008). Our model includes two MAPK and the NF-κB pathways for expression of genes
encoded for pro-inflammatory molecules. The cytoplasmic signaling pathways in thrombocytes
would appear to be primarily devoted to immunologic responses in support of inflammation since
these cells express Toll-like receptors (Scott and Owens, 2008) and are poised to activate upon
exposure to various pathogens entering the bloodstream.
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Figure 4. Diagram of LPS stimulation of thrombocyte TLR4-linked MAPK pathways leading to
gene expression of IL-6, IL-8 and COX-2. Both the ERK and p38 pathways lead to stimulation
of gene expression for these pro-inflammatory molecules based upon inhibition of ERK and p38
by respective inhibitors. Additionally, results of Scott and Owens (2008) revealed the role of the
NF-κB pathway in support of the pro-inflammatory response of the thrombocyte. All three
pathways would be considered major stimulation cascades for gene expression following Tolllike receptor ligation. Solid arrows represent direct steps in pathways. Dashed arrows represent
multiple steps in pathways.
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APPENDICES
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APPENDIX 1: PRELIMINARY EXPERIMENTATION
Both p38 MAPK and ERK inhibitors interfered with mRNA expression of LPS stimulated
thrombocytes.
In this preliminary experiment, using 70 µM p38 inhibitor on SCWL chicken
thrombocytes, there were significant differences in IL-6, IL-8 and COX-2 mRNA expressions for
LPS (+/-) treated cells compared to negative controls (-/-) and thrombocytes exposed to p38
MAPK inhibitor (+/+) (Fig. A1A, B, and C). Using 25 µM ERK inhibitor on SCWL chicken
thrombocytes, there were significant differences in IL-6, IL-8 and COX-2 mRNA expression
levels between control cells (-/-) and those treated with LPS (+/-) (Fig. A2A, B and C). The
expression levels of cells treated with ERK inhibitor and LPS (+/+) were well below the
expression levels of LPS (+/-) treated cells.
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Figure A1. Interleukin-6 (IL-6) (A), interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2)
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without
p38 MAPK inhibitor SB203580 (70 µM), and then 1h incubation of thrombocytes (1 x 107) at
41°C in the presence or absence of S. minnesota lipopolysaccharide (LPS: 10 µg/mL). The
mRNA expression of all three varied relative to LPS and p38 MAPK inhibitor treatment
combinations. Data are presented as means ± SEM (n=6). **P≤0.01.
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Figure A2. Interleukin-6 (IL-6) (A), interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2)
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without
ERK inhibitor (25 µM), and then 1h incubation of thrombocytes (1 x 107) at 41°C in the presence
or absence of S. minnesota lipopolysaccharide (LPS: 10 µg/mL). The mRNA expression of all
three varied relative to LPS and ERK inhibitor treatment combinations. Data are presented as
means ± SEM (n=6). **P ≤ 0.01.
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APPENDIX 2: MICROARRAY DATA
Both p38 MAPK and ERK Inhibitors Interfere with mRNA Expression of Numerous Cytokines,
Chemokines, and TLR-linked Signal Molecules in LPS-Stimulated Thrombocytes
Data from experiments in our laboratory indicated intact ERK and p38 MAPK signal
pathways in chicken thrombocytes. With this knowledge, RNA samples were subjected to
microarray analysis of approximately 4,000 genes. Examples of affected gene expression can be
found in Appendix 2. While this analysis was intended to expand our knowledge of the scope of
molecules affected by TLR4-linked pathways, the depth of information gained proved to be
limited.
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Gene Name
MD-2
TLR2
(isoform 1)
TLR3
TLR4
TLR5
TLR7
TLR15
TAB1
NFκB (p50)
MKK3
p38
cFos
TRAF6
TAK1
IkB

Genbank
Accession #
XM_418301
CK607640
NM_001011691
NM_001030693
BI066471
BM440145
CK611396
NM_001006240
CK608565
NM_001012787
BQ038538
CK607079
CK607050
BM426610
NM_001001472

Con vs. LPS
-1.838
+1.737
+2.669
+4.266
+2.336
+7.316
-2.288
+2.638
-1.595
-2.212
+2.385

Con vs. p38
Inh.
+1.869

+1.893

-2.506

LPS vs. LPS
+ p38 Inhib.
+1.869
-1.736
+1.893
-1.748
-

p38 Inh. vs.
Inh. + LPS
-1.704

+1.679

-2.506
-3.497

+2.497

-2.387
-1.605
+2.085

-2.227
+1.514

Table A1. List of Toll-like receptor pathway-linked genes differentially expressed in untreated
control chicken thrombocytes versus thrombocytes exposed to LPS, and p38 inhibitor.
Expression was determined by microarray, and genes in the list exhibited at least a +/-1.5 fold
change in expression.
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Gene Name
TLR2
(isoform 1)
TLR3
TLR4
TLR5
TLR7
TLR21
TAB1
NFκB (p50)
MKK3
p38
cFos
MyD88

Genbank
Accession #
CK607640
NM_001011691
NM_001030693
BI066471
BM440145
CK609262
NM_001006240
CK608565
NM_001012787
BQ038538
CK607079
CK613540

Con vs. LPS
-1.838
+1.737
+2.669
+4.266
+2.336

Con vs.
ERK Inh.

LPS vs. LPS
+ ERK
Inhib.

ERK Inh.
vs. Inh. +
LPS

+2.038
+2.164
-4.237
-9.091
-1.637
+3.147

-2.288
+2.638
-1.595
-2.212
+2.385

-2.398
-5.917
+1.638

+2.275
-1.898
+1.548

Table A2. List of Toll-like receptor pathway-linked genes differentially expressed in untreated
control chicken thrombocytes verses thrombocytes exposed to LPS, and Erk inhibitor.
Expression was determined by microarray, and genes in the list exhibited at least a +/-1.5 fold
change in expression.
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Gene Name

Genbank
Accession #

Con vs. LPS

Con vs. p38
Inh.

LPS vs. LPS
+ p38 Inhib.

p38 Inh. vs.
Inh. + LPS

chCCL20
IL-1β
iNOS
MIP-1β
IL-18
chCXCLi1(IL8)
chCCLi1
IL-6
IL-4
IL-16
IL-12β
PDGFβ mRNA
chCCLi3
IL12α
chCCLi7

CK613680
CK607391
CK611178
CK611404
CK613996
CK610286
CK609462
CK613692
AJ621249
CK614630
AJ564201
CK609072
CK613216
AY262751
CK610423

+12.79
+5.756
+5.744
+5.548
+4.312
+4.071
+2.612
+1.964
+1.773
+1.750
-2.008
+1.268
-1.321

-2.439
+1.600
+1.002
-6.329
+6.088
-2.899
+8.221
-1.376
-7.143
+1.421
-1.105
+1.507
-2.387
-2.481
+2.305

-1.538
-2.770
-2.392
+1.346
-1.443
+1.126
+1.182
-2.717

+1.198
-1.333
-3.021
+1.035
+1.040
+1.246
+4.410

+1.037
+3.865
-1.062
+2.498

-1.639
+1.278
-1.122

-1.008

-2.037

+1.418

Table A3. List of cytokine and chemokine genes differentially expressed in untreated control
chicken thrombocytes verses thrombocytes exposed to LPS, and p38 inhibitor. Expression was
determined by microarray, and genes in the list exhibited at least a +/-1.5 fold change in
expression.
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Gene Name

Genbank
Accession #

Con vs. LPS

Con vs.
ERK Inh.

LPS vs. LPS
+ ERK
Inhib.

ERK Inh. vs.
Inh. + LPS

chCCL20
IL-1β
iNOS
MIP-1β
IL-18
chCXCLi1(IL8)
chCCLi1
IL-6
IL-4
IL-16
IL-12β
PDGFβ mRNA
chCCLi3
IL12α
chCCLi7
chCCL5

CK613680
CK607391
CK611178
CK611404
CK613996
CK610286
CK609462
CK613692
AJ621249
CK614630
AJ564201
CK609464
CK613216
AY262751
CK610423
CK609464

+12.79
+5.756
+5.744
+5.548
+4.312
+4.071
+2.612
+1.964
+1.773
+1.750
-2.008
+1.268
-1.321

+1.352
+1.447
+2.369
+1.296
+4.59
+1.369
+3.831
-1.357
+1.105
+2.988
-1.422
+1.555
-1.337
-6.289
+1.627

-6.944
-1.456
+1.041
-3.021
+1.062
-1.431
+1.399
-2.309

+1.361
+1.057
+1.024
+1.416
-1.002
+4.789
-1.048
+1.152

+1.786
+2.516
+1.25
-1.029

+1.046
+1.784
+1.018
+1.258

+1.981
-8.403

+2.196

+1.418

Table A4. List of cytokine and chemokine genes differentially expressed in untreated control
chicken thrombocytes verses thrombocytes exposed to LPS, and Erk inhibitor. Expression was
determined by microarray, and genes in the list exhibited at least a +/-1.5 fold change in
expression.
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